Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial.

Belén AlejosN Stella-AscarizR MontejanoJ Rodriguez-CentenoC SchwimmerJ I BernardinoB RodesS EsserC GoujardR Sarmento-CastroR De MiguelA Esteban-CantosC WalletF RaffiJ R Arribasnull null

Published in: HIV medicine (2019)

Both age and HIV RNA viral load correlated with shorter blood telomere length in untreated persons living with HIV. These results suggest that HIV infection and age have synergistic and independent impacts upon immunosenescence.

Keyphrases

hiv positive
antiretroviral therapy
hiv infected
men who have sex with men
human immunodeficiency virus
south africa
clinical trial
hiv infected patients
hiv aids
hiv testing
study protocol
randomized controlled trial
open label
cancer therapy
drug delivery
phase ii